INTRODUCTION
Neuron-glia interactions are mediated in part by the release of substances from glial cells (Barres, 2008; Wang and Bordey, 2008; Halassa and Haydon, 2010; Perea and Araque, 2010) . Studies on in situ preparations and in vivo models suggest that astroglial release of molecules like amino acids, peptides, and nucleotides modulates electrical activity in neurons (Parri et al., 2001; Angulo et al., 2004; Fellin et al., 2004; Liu et al., 2004) , synaptic transmission (Fiacco and McCarthy, 2004; Panatier et al., 2006; Jourdain et al., 2007; Perea and Araque, 2007; Panatier et al., 2011) , and blood flow (Gordon et al., 2008; Petzold et al., 2008) . Recent studies show that glial release influences memory formation (Suzuki et al., 2011) , motor coordination (Kakegawa et al., 2011) , and respiration (Gourine et al., 2010; Huxtable et al., 2010) . Calcium-dependent exocytosis has been proposed as a mechanism for glial substance, also named ''gliotransmission,'' release based on evidence that astroglial cells express vesicular transmitter transporters (Bezzi et al., 2004; Ormel et al., 2012) and components of the exocytotic machinery (Wilhelm et al., 2004; Zhang et al., 2004; Schubert et al., 2011) and that they show calcium-dependent release in vitro (Parpura et al., 1994; Araque et al., 2000; Mothet et al., 2005; Li et al., 2008; Marchaland et al., 2008) and in situ (Pasti et al., 1997; Bezzi et al., 1998 ; for reviews see Parpura and Zorec, 2010; Perea and Araque, 2010) . However, the physiologic relevance of exocytosis in astroglial cells is controversial (Fiacco et al., 2009; Hamilton and Attwell, 2010; Nedergaard and Verkhratsky, 2012) , because there are very few experimental models to address this topic in vivo.
We developed a new transgenic approach to block calciumdependent exocytosis in vivo by temporally controlled, cellspecific expression of clostridial botulinum neurotoxin serotype B light chain (BoNT/B) using the Cre/loxP system. BoNT/B blocks exocytosis efficiently by cleaving vesicle-associated membrane protein 2/synaptobrevin 2 (VAMP2), a component of the soluble N-ethylmaleimide-sensitive factor-attachment protein receptor (SNARE) complex (Schiavo et al., 1992) . In addition, BoNT/B cleaves VAMP1 and VAMP3 (Humeau et al., 2000) . We validated the function of the transgene by ubiquitous and neuron-specific expression using suitable Cre recombinase (Cre)-expressing lines.
To reveal potential physiological roles of glial exocytosis in vivo we focused on the retina as a highly accessible sensory system. The predominant glial element of the retina are Mü ller cells, which represent a subtype of astroglia. They span across retinal layers and contact all neurons (Reichenbach and Bringmann, 2010) . Mü ller cells ensheath synapses in plexiform layers (Burris et al., 2002) , they express VAMP2 and VAMP3 (Roesch et al., 2008) , and they influence the activity of retinal neurons by the release of substances (Newman and Zahs, 1998; Newman, 2003; Stevens et al., 2003; Bringmann et al., 2006) . To block glial exocytosis, we targeted the toxin to Mü ller cells using a transgenic line, where the expression of tamoxifen-inducible Cre recombinase (CreER T2 ) is controlled by promoter elements of the glutamate/aspartate transporter (Glast/Slc1a3; Slezak et al., 2007) . Our results show that toxin-mediated elimination of VAMPs in Mü ller cells inhibits vesicular glutamate release and impairs volume regulation in these cells, but does not affect retinal histology and visual processing.
RESULTS

Generation and Validation of iBot Mice
To generate the transgene, we inserted cDNA encoding for BoNT/B in a cassette that enables Cre-dependent induction of gene expression and EGFP-mediated labeling of cells (Endoh et al., 2002;  Figure 1A ). Out of 13 founder lines, two showed germline transmission. One of these lines, B6;FVB-Tg(CAGboNT/B,EGFP)U75-56Fwp/J (JAX Stock No. 018056), subsequently referred to as the iBot line, was retained for further analysis and validated in two ways. First, iBot mice were crossed to a transgenic line, where Cre is expressed in all cells (Tg(CMVCre); Dupé et al., 1997) . Ubiquitous induction of the toxin should phenocopy the perinatal lethality of VAMP2 knockout mice (Schoch et al., 2001) . Indeed, bigenic mice were born at (B) Perinatal lethality among bigenic, monogenic, and wild-type offspring from matings between the iBot line and the Tg(CMV-Cre) line with ubiquitous expression of constitutively active Cre (n = 110 pups from 19 litters). Inset, fraction of pups with indicated genotypes. Note the drastically enhanced perinatal lethality and reduced number of pups in bigenic (n = 12 pups) compared to monogenic (Cre: n = 29; Tox: n = 36) or wild-type mice (n = 33; Pearson's Chi square test). (C) Mean amplitudes of synaptic responses of Purkinje cells to parallel fiber stimulation at indicated intensities. Whole-cell patch-clamp recordings from Purkinje cells of Tam-injected bigenic mice with neuronal expression of BoNT/B (red filled circles; n = 11 PCs; n = 3 animals, iBot 3 Tg(Prnp-CreER T )) or of monogenic littermates (black empty circles; n = 8 PCs; n = 4 animals, iBot a significantly lower rate compared to monogenic and wild-type littermates and notably, all bigenic offspring died within 1 day after birth, whereas perinatal death rates among control mice were significantly lower ( Figure 1B ). Second, we tested whether neuronal expression of BoNT/B inhibits SNARE-dependent synaptic transmission (Poulain et al., 1988) . To this end, iBot mice were crossed with a line, in which the prion promoter targets an inducible version of Cre (CreER   T   ) to cerebellar neurons (line 28.6, Tg(Prnp-CreER T ); Weber et al., 2001 ). Whole-cell patch-clamp recordings from Purkinje cells revealed a strong reduction of synaptic responses to parallel fiber stimulation in Tamoxifen (Tam)-injected bigenic mice compared to Tam-injected monogenic littermates ( Figure 1C ). Immunohistochemical staining revealed the presence of EGFP, which is coexpressed with the toxin, in the cerebellar granular and molecular layer of bigenic mice ( Figure 1D ).
Together, these results proved that the iBot line allows for cell-specific block of SNARE-dependent exocytosis.
Inhibition of Vesicular Glutamate Release from Retinal
Mü ller Cells by BoNT/B Expression Next, we induced BoNT/B expression in retinal glia by crossing iBot mice with the Tg(Glast-CreER T2 )T45-72 line, which expresses Tam-dependent Cre recombinase in Mü ller cells (Slezak et al., 2007) . Since the toxin cannot be visualized, we used immunohistochemical staining for EGFP to detect the transgene in Mü ller cells. As shown in Figure 2A , adult Tam-injected bigenic mice showed EGFP expression in cellular retinaldehyde binding protein (CRALBP)-positive Mü ller cells, whereas monogenic littermates showed no EGFP staining. The targeting efficacy was on average 55% ± 8% EGFP-positive cells among all CRALBP-positive Mü ller cells (n = 4 bigenic mice). The limited sensitivity of immunohistochemical detection may underestimate the targeting efficacy. To test whether the toxin is active, we determined retinal VAMP2 levels by surface plasmon resonance (Ferracci et al., 2005) . In retinal lysates from Tam-injected bigenic mice, levels of VAMP2 normalized to synaptophysin (SYP) content were significantly decreased compared to vehicle-injected bigenic mice or Tam-injected monogenic or wild-type littermates ( Figure 2B ) indicating proteolyic activity of the toxin in retinae from Tam-injected bigenic mice. To address whether BoNT/B expression blocks calciumdependent exocytosis from Mü ller cells, we established an assay to measure calcium-induced glutamate release from acutely isolated cells. We evoked intracellular calcium transients by UV-induced uncaging of calcium from the photolabile chelator o-nitrophenyl EGTA (NP-EGTA) and we visualized cellular glutamate release by a modified version of a sensitive fluorometric enzyme assay (Akagi et al., 2003; Figures 2C-2E) . End product of the glutamate-specific reaction is the fluorophore resorufin, which was produced and detected outside the cells ( Figures 2C and 2D ). UV stimulation of Mü ller cells from Taminjected monogenic mice resulted in a robust and transient increase of resorufin fluorescence above their endfeet ( Figures  2D and 2E ). Several control experiments confirmed that this signal reflected local calcium-evoked glutamate release from Mü ller cells. The UV-induced transient was much smaller, when it was measured at 30 mm distance from the endfeet (data not shown), when NP-EGTA was omitted and when glutamate-converting enzymes were removed from the extracellular solution ( Figure 2E ). This assay allowed us to test whether toxin expression reduces glutamate release from Mü ller cells. Our recordings revealed that indeed, the amplitude of the UV-induced resorufin signal was significantly reduced in EGFP-positive Mü ller cells of Tam-injected bigenic mice compared to cells from Tam-injected monogenic mice ( Figure 2E ). Notably, bafilomycin A1, which blocks vesicular uptake of glutamate (Moriyama et al., 1990) , reduced the calcium-induced fluorescence transients in cells from Tam-injected monogenic mice to the same extent as BoNT/B ( Figure 2E ).
These experiments provided direct evidence for vesicular glutamate release from Mü ller cells and confirmed its reduction by transgenic expression of BoNT/B, which validates our model at the cellular level. The fact that bafilomycin or the toxin did not completely abolish the signal suggests the presence of nonvesicular glutamate release.
Retinal Morphology after BoNT/B Expression in Mü ller Cells
Next, we asked whether glial expression of the toxin affects the retinal morphology. We first examined retinae in living iBot mice crossed with Tg(Glast-CreER T2 ) mice using spectral domain optical coherence tomography (OCT) and scanning laser ophthalmoscopy (SLO) (Figure 3 ). OCT imaging revealed normal retinal layering in Tam-injected bigenic mice as in their monogenic littermates ( Figure 3A) . Similarly, SLO imaging did not reveal differences between bi-and monogenic mice, except for the presence of autofluorescence ( Figure 3B ), which was caused by EGFP expression in Mü ller cells. To further examine the retinal morphology, we performed immunohistochemical staining of retinal sections from Tam-injected mice with celland layer-specific markers ( Figure 3C ). These experiments revealed no detectable differences in the histology of retinae from Tam-injected monogenic and bigenic mice (Figures 2A and 3C ). Finally, we addressed whether toxin expression in Mü ller cells affects the ultrastructure of the retina by electron microscopy. However, a comparison of Tam-injected mono-and bigenic 
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Volume Regulation after BoNT/B Expression in Mü ller Cells
Previous studies suggested that a glutamatergic-purinergic signaling pathway prevents hypoosmotic swelling of Mü ller cells in the rodent retina by vesicular release of glutamate (Wurm et al., 2008 (Wurm et al., , 2010 ; Figure 4A ). Therefore, we tested whether this pathway was defect in BoNT/B-expressing Mü ller cells. Mü ller cells from Tam-injected bigenic mice, which expressed the BoNT/B transgene as indicated by the presence of EGFP ( Figure 4B ), had similar cross sectional areas as cells from Tam-injected monogenic mice ( Figure 4C ). However, these cells swelled in hypotonic solution, while Mü ller cells from monogenic animals maintained their cell volume ( Figure 4D ) indicating a toxin-induced defect in volume regulation. If the swelling of toxin-expressing Mü ller cells was due to the block of glutamate release, coapplication of glutamate should prevent the swelling of these cells. As shown in Figure 4D , this was indeed the case thus confirming the involvement of exocytotic glutamate release in volume regulation. Vascular endothelial growth factor (VEGF), which activates the volume-regulating cascade upstream of glutamate release (Wurm et al., 2008) , failed to abolish swelling of Mü ller cells from bigenic mice ( Figure 4D ), whereas it prevented hypotonic swelling of Mü ller cells from monogenic mice due to barium-induced block of inwardly rectifying potassium channels (Wurm et al., 2008 ) ( Figure 4D ). Toxin expression in Mü ller cells may have provoked reactive gliosis and thereby perturbed glial volume regulation (Pannicke et al., 2004 (Pannicke et al., , 2005 Sene et al., 2009 ). However, levels of glial fibrillary acidic protein (GFAP) were similar in retinae from Tam-injected mono-and bigenic mice (data not shown). Additional hallmarks of Mü ller cell reactivity are a downregulation of potassium inward currents and an increase in membrane capacitance (Pannicke et al., 2005) . Our patch-clamp recordings revealed comparable amplitudes of inward currents and even a significant (p < 0.02; Student's t test) decrease in membrane capacitance in acutely isolated Mü ller cells from Tam-injected bigenic (2.4 ± 0.7 nA; 40 ± 12 pF; n = 33 cells from 8 mice) compared to monogenic mice (2.2 ± 0.6 nA; 49 ± 12 pF; n = 29 cells, 7 mice). The VEGF-induced glutamate release from Mü ller cells also induces swelling of neurons in the ganglion cell layer independently from a hypo-osmotic challenge (Wurm et al., 2008) . To test whether this effect was eliminated by glial toxin expression, we measured the size of neuronal somata that were close to endfeet of toxin-and EGFP-expressing Mü ller cells from Taminjected bigenic mice ( Figure 4E ). Indeed, these neurons did not show VEGF-induced swelling, whereas the effect was present in cells from Tam-injected monogenic animals (Figure 4E, F) . As for Mü ller cells, the mean cross sectional area of untreated neurons was similar in mono-and bigenic mice ( Figure 4C ). Together, these data suggest that toxin-induced block of glial exocytosis perturbs volume regulation in Mü ller cells and inhibits swelling of neuronal cells induced by glial glutamate.
Retinal Function after BoNT/B Expression in Mü ller Cells
We next investigated whether toxin expression in Mü ller cells affects retinal function at different levels of integration.
First, we used multielectrode arrays (MEAs) to record spike activity in the retinal ganglion cell layer in response to visual stimuli ex vivo ( Figure 5 ). Previous studies showed that glial glutamate release inhibits light-evoked ganglion cell activity (Newman and Zahs, 1998) . We stimulated retinae with different monochromatic visual stimuli including fullfield flashes, drifting bars, and drifting gratings to explore the spatial and temporal response properties of ganglion cells. Ganglion cells from adult Tam-injected mono-and bigenic mice did not differ in their responses to simple steps in light intensity ( Figure 5A ) or to sinusoidal drifting gratings of various temporal and spatial frequency and contrast ( Figure 5B ). Ganglion cells show accelerated response kinetics in a high-contrast environment (contrast adaptation; Baccus and Meister, 2002) . We also observed this phenomenon ( Figure 5C ), and there was no difference between bi-and monogenic mice. Finally, we measured the velocity tuning of ganglion cell spikes in response to bars drifting across the receptive field at various velocities ( Figure 5D ). Again, there was no difference between the two mouse lines. Second, we recorded electroretinograms (ERGs) to measure light-evoked electrical responses of retinal layers in vivo using single flash and flicker stimuli  Figure 6 ). However, our experiments revealed no detectable differences in the retinal responses of Tam-injected bigenic mice compared to monogenic littermates (Figure 6 ). Third, we performed behavioral tests to assess visual function in mice (Figure 7 ; Arqué et al., 2008) . For these experiments, we used Tam-injected bi-(n = 12-13) or monogenic (n = 12-17) males. In the novel object recognition (NOR) test, Tam-injected bi-and monogenic mice spent more time exploring the novel object compared to the old one, but the mean fraction of time was similar in both groups ( Figure 7A ). In the water maze test with a visible platform, bi-and monogenic mice found the visible platform with similar latencies ( Figure 7B) and in the open field test, mice from both groups spent similar times in the central zone ( Figure 7C ). Finally, we tested whether toxin expression in glial cells affects the photic entrainment of the circadian rhythm, which is mediated by photoreceptors and light-sensitive cells in the ganglion cell layer (Golombek and Rosenstein, 2010) . To this end, we recorded running-wheel activity of bi-and monogenic mice during a 12/12 hr light/dark cycle before and after Tam-induced toxin activity. We observed that the light-induced onset and duration of running periods and the fraction of nocturnal activity compared to total activity were unaffected by Tam-induced toxin expression in glial cells (Figures 7D-7G) .
Collectively, these results indicated that the response properties of ganglion cells, light-evoked potentials in retinal layers, daylight vision, and the retinal control of circadian activity are not noticeably affected by toxin expression in Mü ller cells.
DISCUSSION
To test the physiologic relevance of SNARE-dependent exocytosis in glial cells in vivo, we generated and validated a transgenic mouse line for conditional expression of BoNT/B. Our iBot mice provide a flexible tool to study the functions of VAMP1-3 in cells of interest (Proux-Gillardeaux et al., 2005) , and they complement the existing arsenal of models for cell-specific block of SNAREdependent exocytosis (Yamamoto et al., 2003; Nakashiba et al., 2008; Zhang et al., 2008; Kerschensteiner et al., 2009; Kim et al., 2009) .
We focused on the role of glial exocytosis in the retina and targeted BoNT/B to Mü ller cells by crossing iBot mice with the Tg(Glast-CreER T2 ) line (Slezak et al., 2007) . Using a sensitive fluorometric assay, we provide direct evidence for calciumdependent vesicular release of glutamate from Mü ller cells. The fact that this phenomenon occurred in acutely isolated cells corroborates the idea that astroglial cells are capable of exocytotic release in vivo. Our observation that neither BoNT/B nor bafilomycin fully blocked calcium-dependent release of glutamate from Mü ller cells suggests a contribution by nonvesicular mechanisms (Fiacco et al., 2009; Hamilton and Attwell, 2010) .
Our results indicate a specific function of vesicular glutamate release from Mü ller cells. Using a battery of tests, we show that toxin expression in Mü ller cells does not affect retinal structure or visual processing. This lack of effect may be due to limitations of our transgenic mouse model, which does not target all Mü ller cells. Unfortunately, there is currently no experimental approach that allows us to accomplish this (Pfrieger and Slezak, 2012) . On the other hand, we find that exocytotic glutamate release mediates glial volume regulation. Toxin-expressing Mü ller cells were unable to counteract a volume increase induced by hypotonic solution and this defect was compensated by coapplication of glutamate. Similar osmotic swelling of Mü ller cells was observed in knockout mice with impaired purinergic signaling (Wurm et al., 2010) . Together, these results support the during low (gray) and high (black) contrast episodes, respectively. The latency is calculated from the Gaussian fit (solid lines). Right, distribution of latency differences between high and low contrast in ganglion cells from monogenic (black) and bigenic (red) 
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Impact of Glial VAMPs on Retinal Function hypothesis that glial volume regulation depends on a complex signaling pathway that implies exocytotic release of glutamate ( Figure 4A ; Wurm et al., 2008) . We note that BoNT/B may also affect constitutive exocytosis and vesicular transport in the endosomal pathway (Proux-Gillardeaux et al., 2005; Hamilton and Attwell, 2010) . Our observation that glutamate fully restored volume regulation in toxin-expressing glial cells suggests that the glial release of ATP or adenosine, which is downstream from glutamate ( Figure 4A ), is mediated by nonvesicular release. Taken together, our results suggest that calcium-induced vesicular release plays a role in glial physiology and that its contribution depends on the astroglial cell type. This is in line with previous studies on an alternative mouse model to study gliotransmission in vivo. Block of exocytosis in GFAP-positive cells by a dominant-negative SNARE domain of VAMP2 impaired glutamatergic synaptic transmission in hippocampal slices (Pascual et al., 2005) and perturbed sleep homeostasis, but left other brain functions unaffected Halassa et al., 2009 ). On the other hand, transgenic induction of calcium transients in GFAP-positive cells did not affect excitatory synaptic activity (Fiacco et al., 2007) and plasticity in hippocampal slices (Agulhon et al., 2010) . A full understanding of how gliotransmission contributes to brain development, function, and pathology clearly necessitates new experimental approaches to localize and perturb the different release mechanisms in astroglial cells in vivo.
EXPERIMENTAL PROCEDURES
Generation of Transgenic Mice
BoNT/B (Whelan et al., 1992) was amplified from the pBN13 vector (kind gift from T. Galli) by PCR and cloned into the pCAGGS-lox-STOP-lox-IRES-EGFP plasmid (Endoh et al., 2002 ; a kind gift from Dr. M. Endoh). Plasmids containing the construct were amplified, purified (QIAGEN Plasmid Maxi Kit), linearized, and injected into FVB/N mouse oocyte (Institut Clinique de la Souris, ICS, Illkirch, France). Transgenic founders were backcrossed on the C57Bl/6 background, and each line was screened for germline transmission. For genotyping, genomic DNA was isolated from tail biopsies (DirectPCR Lysis Reagent Tail; Viagen Biotech) and subjected to standard PCR using specific primers (Eurogentec) (EGFP: EGFP6F 5 
Tam Administration
Tam (Sigma) was administered to adult (1-3 months old) animals by intraperitoneal injection (2 mg from stock of 20 mg/ml in sunflower oil / ethanol 9:1). Experiments were performed 2-4 weeks after the last injection. Postnatal administration (5-day-old pups) was achieved by intraperitoneal injection of lactating mothers (1 mg from 10 mg/ml stock) for 5 consecutive days at 24 hr intervals. Excess Tam was wiped off to exclude Tam ingestion by suckling pups. Congestion of the vulva in female pups indicated that Tam had passed to pups. Retarded growth of pups was counteracted by hydrated food pellets after weaning. Tam administration to lactating mothers did not diminish their fertility or interfere with subsequent pregnancies or deliveries.
Measurement of BoNT/B Activity
Measurements of VAMP2 and SYP levels in retinal lysates were performed by surface plasmon resonance using antibodies directed against VAMP2 (Cl 69.1) and SYP (Cl 7.2; Synaptic Systems) coupled to a CM3 sensor chip of a Biacore 3000 system. A nonimmune IgG (Jackson Immunoresearch) was used to reduce nonspecific binding as described (Ferracci et al., 2005) . Frozen retinae were sonicated (3 3 2 s, 40W) in 300 ml of 10 mM HEPES/NaOH (pH 7.4), 0.32 M sucrose, 5 mM DTT as described (Marconi et al., 2008) and 10,000 3 g lysate supernatants were incubated at 37 C during 30 min.
Samples were diluted in analysis buffer (50 mM Tris/HCl [pH 7.4], 0.4 M NaCl) and the surface plasmon resonance signal was measured 20 s after the end of each injection (20 ml/min).
Measurement of Calcium-Induced Glutamate Release
We used a fluorometric enzyme assay based on the Amplex Red Glutamic Acid kit (Invitrogen) to visualize glutamate release from acutely isolated Mü ller cells, which were identified by their unique morphology. Retinae were incubated in papain (0.2 mg/ml; Roche Molecular Biochemicals) for 30 min at 37 C in the dark in Ca
2+
-and Mg 2+ -free extracellular solution (140 mM NaCl, 3 mM KCl, 10 mM HEPES, 11 mM glucose [pH 7.4]), which was supplemented with glutamine (0.25 mM), glutamate (0.5 mM), methionine sulfoximine (5 mM, Sigma) to block glutamine synthetase, and a photolabile calcium chelator (O-nitrophenyl ethylene glycol tetraacetic acid acetoxymethyl; NP-EGTA, 10mM; Invitrogen). After several washes with extracellular solution, to which MgCl 2 (1 mM) and CaCl 2 (2 mM) were added, retinae were triturated in extracellular solution containing the components of the Amplex Red Glutamic Acid kit (100 mM Amplex Red reagent, 0.5 U/ml horse radish peroxidase, 0.16 U/ml L-glutamate oxidase, 1.0 U/ml L-glutamate-pyruvate transaminase, 400 mM L-alanine), NP-EGTA (10 mM), methionine sulfoximine (200 mM), and D, L-threo-beta-benzyloxyaspartate (200 mM) to block glial glutamate uptake. The cell suspension was mixed with 1% agarose and incubated for 15 min in the recording chamber at 37 C. In some experiments, bafilomycin A1
(200 nM, Biozol) was added. Resorufin fluorescence was imaged by confocal laser microscopy (LSM510 Meta, 1003/1.3 Plan-Neofluar oil, Zeiss; 543 nm helium-neon laser, 585 nm long pass filter, pinhole maximally open) above Mü ller cell endfeet. Calcium transients were induced by four UV pulses (351 nm/364 nm Enterprise UV Laser, 500 ms at maximal intensity) to release calcium from NP-EGTA. Control experiments using fluo-4/AM (488 nm argon laser; 505-550 nm band-pass filter) confirmed that each cell tested (15 out of 15) showed UV-induced calcium transients. Peak amplitudes were calculated as difference between mean fluorescence intensity across four time points acquired before and after the UV pulses.
Immunohistochemical Staining
Retinae were fixed with 4% paraformaldehyde by transcardiac perfusion of mice or by incubation of isolated retinae in fixative for 45 min. Cryosections or vibratome sections (embedded in 3% agarose) were blocked (2% bovine serum albumin, Sigma; 5% normal goat or donkey serum plus 0.3% Triton X-100 or 0.3% Triton X-100 plus 1% DMSO) and stained overnight with biotinylated PNA (1:200, Sigma), with the nuclear stain TO-PRO-3 (1:1000, Invitrogen) or with primary antibodies directed against CRALBP (mouse, 1:1000, Abcam), GFAP (mouse, 1:200, Sigma), Kv3.1b/KCNC1 (mouse, 1:200, Sigma), GFP (rabbit, 1:1000; Abcam), protein kinase C alpha (PKCa; rabbit, 1:200, Genetex), vesicular glutamate transporter 1 (VGLUT1/SLC17A7; guinea pig, 1:200, Synaptic Systems), and with secondary antibodies coupled to Alexa Fluor 488 and Alexa Fluor 555 (Invitrogen) or Cy2-conjugated streptavidin (Jackson Immunoresearch) for 1-3 hr at room temperature. Sections were mounted in Mowiol (16.6% w/v, in PBS: glycerin 2:1; Calbiochem). Images were taken with a laser scanning microscope (LSM 510 Meta) and an Achroplan 633/0.9 water immersion objective (Zeiss).
Electron Microscopy
Mice were anesthetized by intraperitoneal injection of Ketamine (200 mg/kg) and Xylazine (25 mg/kg) and fixed by transcardiac perfusion with glutaraldehyde (2.5% in PBS at 7.4). Eyes were dissected and fixed for 1 hr in glutaraldehyde (2.5%) at room temperature (20 C-24 C). After three washes with PBS, eyes were postfixed (1% OsO 4 in PBS for 1 hr), dehydrated (ethanol at 25% for 10 min; 50% for 10 min, 70% for 10 min, 95% for 10 min and 100% for 3 3 10 min; propylene oxide for 3 3 10 min) and embedded (Araldite M: propylene oxide at 1:1 for 1 hr followed by Araldite M for 2 3 2 hr at room temperature; polymerization at 60 C for 3 days). Ultrathin sections were contrasted with uranyl acetate and inspected on a transmission electron microscope (HITACHI 7500 with AMT camera, Hamamatsu).
Volume Regulation
Acutely isolated retinal slices (thickness, 1 mm; custom-made cutter) were incubated in extracellular solution (see above) containing the vital dye Mitotracker Orange (10 mM, excitation: 543 nm, emission: 560 nm long-pass filter; Invitrogen), which is taken up by Mü ller cells . Somata of Mü ller cells were imaged at the plane of their maximal size using confocal microscopy (LSM 510 Meta). In bigenic mice cells, which displayed EGFP fluorescence (excitation: 488 nm; emission: 505 nm long-pass filter), were selected. Hypotonic solution (60% of control osmolarity using distilled water) and test substances were applied for 4 min. Barium chloride (1 mM) was added to the extracellular solution 10 min before measurements. To study volume changes in neuronal cell bodies, retinae were positioned in a perfusion chamber with their vitreal surface up, labeled with FM1-43 (2 mM, Invitrogen for 3 min; excitation 488 nm; emission 505 nm long-pass filter) to outline cells and examined by confocal microscopy (LSM 510; Achroplan 633/0.9 water immersion objective, Zeiss; pinhole 172 mm; optical section 1 mm). Image stacks were obtained before and after 15 min perfusion with extracellular solution in the absence or presence of test substances. For analysis, the crosssectional areas of fluorescently labeled cell bodies in the ganglion cell or inner nuclear layer of retinal slices were measured (Zeiss LSM Image Examiner Version 3.2.0.70).
Electrophysiological Recordings
Electrophysiological recordings were performed on Purkinje cells in cerebellar slices and on acutely isolated Mü ller cells by the whole-cell patch-clamp technique. Spike activity in the ganglion cell layer of retinae was recorded by MEAs ex vivo. Light-evoked electrical responses of retinal layers were recorded by ERGs in vivo. Details are described in Supplemental Information.
In Vivo Imaging SLO images were obtained from anesthetized mice immediately after ERG recordings as described previously using a Heidelberg Retina Angiograph (HRA I) (Seeliger et al., 2005) . Images were acquired under illumination with an argon laser for fundus autofluorescence and EGFP detection (488 nm) and red-free (RF) imaging of retinal structures (514 nm). OCT imaging was performed immediately after SLO using a Spectralis HRA+OCT device (Heidelberg Engineering) and a broadband superluminescent diode at l = 880 nm as light source . Adaptation for the optical qualities of the mouse eye was achieved as described previously ).
Behavioral Tests
For behavioral tests the animals were kept in ventilated cages (Ehret) in 12/12 hr light/dark cycle with free access to food and water. The tests were performed between hr 2 and 6 of the light phase and registered and analyzed with the ANY-maze software (Stoelting). To assess visual perception of mice several behavioral tests were performed with some modifications (Arqué et al., 2008) . For the NOR test, mice were placed at day 1 for 5 min in the empty open field apparatus (gray PVC box 40 3 40 3 34 cm, illumination 160 lux). At day 2, mice were exposed for 10 min to an object A placed 5 cm from the wall. After 3 min, the animals were exposed for 10 min to two objects: the previous object A and a novel object B, positioned in two opposite corners, 5 cm from the walls. Both objects presented similar textures, shapes, and sizes but distinctive colors (white versus deep blue plastic caps, 4.5 cm diameter, 2.5 cm height, randomly assigned as ''old'' or ''novel''). The novel object recognition was assessed as the percentage of time the mice explored object B compared to the time of exploration of both objects during the second trial (NOR index = (time B/time A + B) * 100).
The Morris water maze consisted of a plastic cylindrical pool (120 cm diameter), which was filled with water (temperature controlled at 22 C ± 1 C, illumination 50 lux at the center of the maze). The water was opaque by the addition of white, nontoxic talcum powder (Pharma Cosmetic). Visual cues were positioned around the pool, 60 to 90 cm from its rim. The pool was divided into four quadrants of equal area and a circular platform (15 cm height, 10 cm diameter) was placed in the same quadrant for all trials. This platform, which stood out of the water, was marked by tape and by a flag. At day 0 (24 hr before the experiment) the mice swam freely for 2 min to find the platform and they were allowed to spend 15 s on the platform (acclimatization). At days 1, 2, and 3 the animals were placed into the water facing the wall of the maze. They were released from four different positions at the pool perimeter, each trial lasted 90 s. The latencies to reach the platform were recorded. For the open field test animals were placed in the center of the open-field area (40 3 40 cm) that was equipped with a video camera placed above the apparatus. Horizontal (locomotion) and vertical (rearings) activities were measured for 10 min.
Actimetry
Transgenic mice were exposed to a 12/12 hr light/dark cycle (lights on at 7 a.m.) in cages equipped with running wheels (diameter 10 cm). Wheelrunning activity was recorded every 5 min (Vitalview acquisition system, Minimitter). Onset and duration of running activity during the dark phase were determined by visual inspection of actograms.
Statistical Analysis
Statistical analyses were performed using indicated tests (STATISTICA 9.1, StatSoft Inc., Maison-Alfort, France). Whiskers in plots represent standard deviation or standard error as indicated. Levels of significance are indicated by asterisks and circles (* p < 0.05; ** p < 0.01; *** p < 0.001).
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